Purchases and Sales Made in Q2 2025 in Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM) during Q2 2025. The information is specifically focused on institutions that hold shares of Eliem Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2025
Q2 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-77.5K- 43.8% |
N/A
|
99.5K
$409K
|
|
|
Aug 13, 2025
Q2 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-159K- 53.0% |
N/A
|
141K
$581K
|
|
|
Aug 11, 2025
Q2 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-171K- 11.4% |
N/A
|
1.33M
$5.47M
|
|
|
Aug 11, 2025
Q2 2025
|
Citigroup Inc
|
SELL
|
- |
-238K- 12.88% |
N/A
|
1.61M
$6.62M
|
|
|
Aug 14, 2025
Q2 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-275K- 72.76% |
N/A
|
103K
$424K
|
|
|
Aug 08, 2025
Q2 2025
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-362K- 53.74% |
N/A
|
312K
$1.28M
|